Skip to content

Kazeem Olalekan

  • BSc (Pharm), MSc(BIT), DipPharmPrac
  • 1h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 2CitationsNumber of citations received by Kazeem's publications. Updated daily.

Co-authors (6)

  • Rodney Gilbert

Publications (5)

  • Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

    • Gilbert R
    • Evans H
    • Olalekan K
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

    • Gilbert R
    • Evans H
    • Olalekan K
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • TOLVAPTAN USE IN SEVERE NEONATAL AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): THE PHARMACEUTICAL CHALLENGE

    • Olalekan K
    • Fox A
    • Gilbert R
    N/AReaders
    N/ACitations
    Get full text
  • TO EVALUATE A PROTOCOL FOR PROMPT MIGRATION FROM AN UNLICENSED TO A LICENSED PRODUCT USING THE NHS CHANGE MODEL IN A PAEDIATRIC CARDIOLOGY SETTING

    • Olalekan K
    N/AReaders
    N/ACitations
    Get full text
  • An evaluation of the level of "pharmacy engagement"​ of preregistration and final year pharmacy students (Abstract 51)

    • Olalekan K
    • Yakubu A
    • Hull H
    • et al.
    N/AReaders
    N/ACitations
    Get full text